Data on cancer vaccines epidemiology reported by investigators at National Cancer Center Research Institute
2007 NOV 12 -- Fresh data on cancer vaccines are presented in the report 'Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.' "Human papillomaviruses (HPV) are believed to be the primary causal agents for development of pre-neoplastic and malignant lesions of the uterine cervix, and high-risk types such as type 16 and 18 are associated with more than 90% of all cervical carcinomas. The E6 and E7 genes of HPV are thought to play causative roles, since E6 promotes the degradation of p53 through its interaction with E6AP, an E3 ubiquitin ligase, whereas E7 binds to the retinoblastoma protein (pRb) and disrupts its complex formation with E2F transcription factors," researchers in Tokyo, Japan report. "Although prophylactic vaccines have become available, it is still necessary to clarify the mechanisms of HPV-induced carcinogenesis because of the widespread nature of HPV infection. Approximately 493,000 new cases of cervical cancer are diagnosed each year with approximately 274,000 mortalities due to invasive cervical cancer," wrote M. Narisawa-Saito and colleagues, National Cancer Center Research Institute. The researchers concluded: "In the present article, the mechanisms of HPV16 E6-and E7-induced multistep carcinogenesis and recently identified functions of these onco-proteins are reviewed." Narisawa-Saito and colleagues published their study in Cancer Science (Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Science, 2007;98(10):1505-11). For additional information, contact M. Narisawa-Saito, National Cancer Center Research Institute, Virology Division, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Publisher contact information for the journal Cancer Science is: Japanese Cancer Association, C, O Japanese Foundation Cancer RESEARCH,1-37-1, Kami-Ikebukuro, Toshima-Ku, Tokyo, 170-0012, Japan. Keywords: Japan, Tokyo, Cancer Vaccines Epidemiology, Biotechnology, Cancer Science, Cancer Vaccines, Cervical Cancer, Cervical Carcinoma, Epidemiology, Gene Therapy, HPV, Human Papillomavirus, Oncology, Women's Health. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2007, Clinical Oncology Week via NewsRx.com.
|
